News

Bedfont® Scientific Limited highlights how using FeNO and CO monitoring can help to support healthier lungs. World Lung Day is an annual global awareness day observed on the 25th of September. The event was established by the Forum of International...

Innovative Smokerlyzer® and NObreath® respiratory devices to be exhibited at the European Respiratory Society International Congress. Bedfont® Scientific Limited, world leaders in breath analysis, is attending the European Respiratory Society (ERS) International Congress to showcase its innovative Smokerlyzer® and NObreath®...

September sees the return to school for children after the summer holidays. While the return to routine is welcomed, it can be challenging for children with asthma. Research by Asthma + Lung UK found that in 2022/2023, there was a...

Bedfont® Scientific Limited hosted an insightful webinar, Navigating IBS: Understanding IBS symptoms, microbiome impact and the role of HMBT, with expert Gastrointestinal Physiologist, Melissa Dooley. The webinar examined IBS symptoms, their overlap with other conditions, and how hydrogen-methane breath testing...

Carbon monoxide (CO) is a harmful gas formed through incomplete combustion and is produced when smoking tobacco. Smoking kills over 8 million people a year and is one of the biggest public health threats the world has ever faced1. This...

New partnership with Medvision for Medical Services Company brings the Gastrolyzer® range to Kuwait. Bedfont® Scientific Limited, world leaders in breath analysis, is pleased to announce its collaboration with Medvision for Medical Services Company in Kuwait. Medvision, a leading distributor...